SAM-CANCELLATION NOTICE.PDF
Published: 11/21/2025
Description
FDA/OAGS/DAO/SSB Amendment Number: 2 Original Solicitation Number: 75F40125R00097 (121683) Title: Post-market Bioequivalence of Generic Drug Products IDIQ Amendment Date: 11/21/2025 Contracting Officer: Ian Weiss Contract Special...
